CTRI/2020/05/025209已完成2 期
AN OPEN LABEL RANDOMISED CONTROL TRIAL ON PASSIVE IMMUNIZATION WITH CONVALESCENT PLASMA IN SEVERE COVID-19 DISEASE - PICP19
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients admitted with RNA PCR proven COVID-19 with
- •severe disease (fever or suspected respiratory infection, plus one of the following; respiratory rate >30 breaths/min, severe respiratory distress, SpO2 < 90% at room air)
- •with Mild ARDS (200 mmHg < PaO2/FiO2 <= 300 mmHg, with PEEP or CPAP >=5 cm H2O, or non-ventilated)
- •or Moderate ARDS (100 mmHg < PaO2/FiO2 <=200 mmHg, with PEEP >=5 cm H2O, or non-ventilated)
- •within 5 to 10 days from initial presentation.
排除标准
- •1. Pregnant mothers
- •2. Patients with age less than 18 years
- •3. Admitted late after 10 days of initial presentation
- •4. Patients refusing consent
研究者
相似试验
已完成
3 期
â??PREVENTION OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSISâ??CTRI/2012/07/002807G B Pant Hospital100
招募中
2 期
Efficacy of Virechana followed by Gomutra-haritaki in the fatty liver disease?CTRI/2021/11/038277AD
已完成
2 期
EFFECT OF VSL#3 IN PATIENTS WITH MICROSCOPIC COLITISCTRI/2008/091/000086CD Pharma India Pvt Ltd30
尚未招募
2 期
Study of the treatment of psoriasis by unani medicineCTRI/2020/03/023697ational Research Institute of Unani Medicine for Skin Disorders
尚未招募
3 期
A STUDY TO EVALUATE THE ROLE OF PROPHYLACTIC OCTREOTIDE IN PREVENTING ERCP INDUCED PANCREATITISCTRI/2016/10/007335SETH GS MEDICAL COLLEGE AND KEM HOSPITA113